OneDigital Investment Advisors LLC cut its stake in McKesson Co. (NYSE:MCK – Free Report) by 48.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,338 shares of the company’s stock after selling 2,175 shares during the period. OneDigital Investment Advisors LLC’s holdings in McKesson were worth $1,156,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of MCK. Distillate Capital Partners LLC boosted its position in shares of McKesson by 127,542.9% in the 2nd quarter. Distillate Capital Partners LLC now owns 35,740 shares of the company’s stock valued at $20,874,000 after purchasing an additional 35,712 shares during the period. Chase Investment Counsel Corp boosted its holdings in shares of McKesson by 50.8% in the second quarter. Chase Investment Counsel Corp now owns 8,985 shares of the company’s stock valued at $5,247,000 after acquiring an additional 3,027 shares during the period. Wealthspire Advisors LLC grew its position in shares of McKesson by 8.9% during the second quarter. Wealthspire Advisors LLC now owns 1,623 shares of the company’s stock worth $948,000 after acquiring an additional 133 shares during the last quarter. Vaughan David Investments LLC IL acquired a new position in shares of McKesson in the 2nd quarter valued at $238,000. Finally, Newbridge Financial Services Group Inc. raised its position in McKesson by 2,143.1% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 1,458 shares of the company’s stock valued at $851,000 after purchasing an additional 1,393 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have commented on MCK. Baird R W upgraded shares of McKesson from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 7th. StockNews.com raised McKesson from a “hold” rating to a “buy” rating in a research note on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft lowered their target price on McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a research note on Wednesday, September 25th. Citigroup lifted their price objective on shares of McKesson from $630.00 to $713.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, JPMorgan Chase & Co. lifted their target price on shares of McKesson from $656.00 to $661.00 and gave the company an “overweight” rating in a report on Wednesday, August 21st. Two investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $631.57.
Insiders Place Their Bets
In other news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the sale, the chief executive officer now owns 78,586 shares in the company, valued at $44,094,604.60. This trade represents a 4.56 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.11% of the stock is owned by corporate insiders.
McKesson Stock Performance
Shares of NYSE:MCK opened at $615.61 on Tuesday. McKesson Co. has a one year low of $431.35 and a one year high of $637.51. The stock has a market cap of $78.15 billion, a PE ratio of 31.88, a price-to-earnings-growth ratio of 1.31 and a beta of 0.44. The business’s fifty day moving average price is $522.14 and its two-hundred day moving average price is $555.17.
McKesson (NYSE:MCK – Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.88 by $0.19. McKesson had a net margin of 0.77% and a negative return on equity of 207.50%. The firm had revenue of $93.65 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same quarter in the previous year, the company posted $6.23 EPS. The firm’s revenue for the quarter was up 21.3% on a year-over-year basis. As a group, equities research analysts predict that McKesson Co. will post 32.81 earnings per share for the current fiscal year.
McKesson Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Monday, December 2nd will be given a dividend of $0.71 per share. The ex-dividend date is Monday, December 2nd. This represents a $2.84 dividend on an annualized basis and a yield of 0.46%. McKesson’s dividend payout ratio (DPR) is currently 14.71%.
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Further Reading
- Five stocks we like better than McKesson
- What Investors Need to Know About Upcoming IPOs
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Business Services Stocks Investing
- Applied Materials Market Capitulates: Now is the Time to Buy
- Learn Technical Analysis Skills to Master the Stock Market
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.